Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3051% below fair value
$44.34+0.14 (+0.32%)
Close on Nov 13, 2026Market cap $64.26BP/E 18.8Yield –
Boston Scientific total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Boston Scientific's total debt was $11.95B at Sep 30, 2026. For fiscal 2025 it was $11.44B, up 6.4% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $11.44B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.44B | +6.4% |
| FY2024 | Dec 31, 2024 | $10.75B | +18.1% |
| FY2023 | Dec 31, 2023 | $9.10B | +1.9% |
| FY2022 | Dec 31, 2022 | $8.94B | -1.4% |
| FY2021 | Dec 31, 2021 | $9.07B | -0.9% |
| FY2020 | Dec 31, 2020 | $9.14B | -8.6% |
| FY2019 | Dec 31, 2019 | $10.01B | +41.8% |
| FY2018 | Dec 31, 2018 | $7.06B | +25.6% |
| FY2017 | Dec 31, 2017 | $5.62B | +2.4% |
| FY2016 | Dec 31, 2016 | $5.48B | -3.4% |
| FY2015 | Dec 31, 2015 | $5.68B | +33.8% |
| FY2014 | Dec 31, 2014 | $4.24B | +0.1% |
| FY2013 | Dec 31, 2013 | $4.24B | -0.4% |
| FY2012 | Dec 31, 2012 | $4.26B | -0.1% |
| FY2011 | Dec 31, 2011 | $4.26B | -21.6% |
| FY2010 | Dec 31, 2010 | $5.44B | -8.1% |
| FY2009 | Dec 31, 2009 | $5.92B | -12.3% |
| FY2008 | Dec 31, 2008 | $6.75B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $11.95B | +3.0% |
| Q2 FY2026 | Jun 30, 2026 | $12.62B | +8.9% |
| Q1 FY2026 | Mar 31, 2026 | $11.03B | -2.5% |
| Q4 FY2025 | Dec 31, 2025 | $11.44B | +6.4% |
| Q3 FY2025 | Sep 30, 2025 | $11.60B | +6.6% |
| Q2 FY2025 | Jun 30, 2025 | $11.59B | +9.6% |
| Q1 FY2025 | Mar 31, 2025 | $11.31B | +6.5% |
| Q4 FY2024 | Dec 31, 2024 | $10.75B | +18.1% |
| Q3 FY2024 | Sep 30, 2024 | $10.89B | +22.3% |
| Q2 FY2024 | Jun 30, 2024 | $10.57B | +16.8% |
| Q1 FY2024 | Mar 31, 2024 | $10.62B | +17.9% |
| Q4 FY2023 | Dec 31, 2023 | $9.10B | +1.9% |
| Q3 FY2023 | Sep 30, 2023 | $8.90B | +3.7% |
| Q2 FY2023 | Jun 30, 2023 | $9.05B | +0.9% |
| Q1 FY2023 | Mar 31, 2023 | $9.01B | -3.2% |
| Q4 FY2022 | Dec 31, 2022 | $8.94B | -1.4% |
| Q3 FY2022 | Sep 30, 2022 | $8.58B | -5.5% |
| Q2 FY2022 | Jun 30, 2022 | $8.97B | -1.5% |
| Q1 FY2022 | Mar 31, 2022 | $9.31B | +2.3% |
| Q4 FY2021 | Dec 31, 2021 | $9.07B | -0.9% |
| Q3 FY2021 | Sep 30, 2021 | $9.09B | -2.7% |
| Q2 FY2021 | Jun 30, 2021 | $9.11B | -4.4% |
| Q1 FY2021 | Mar 31, 2021 | $9.10B | -12.0% |
| Q4 FY2020 | Dec 31, 2020 | $9.14B | -8.6% |
| Q3 FY2020 | Sep 30, 2020 | $9.34B | -14.2% |
| Q2 FY2020 | Jun 30, 2020 | $9.53B | -0.1% |
| Q1 FY2020 | Mar 31, 2020 | $10.34B | +12.0% |
| Q4 FY2019 | Dec 31, 2019 | $10.01B | +41.8% |
| Q3 FY2019 | Sep 30, 2019 | $10.89B | +64.3% |
| Q2 FY2019 | Jun 30, 2019 | $9.54B | +46.9% |
| Q1 FY2019 | Mar 31, 2019 | $9.23B | +60.1% |
| Q4 FY2018 | Dec 31, 2018 | $7.06B | +25.6% |
| Q3 FY2018 | Sep 30, 2018 | $6.63B | +16.6% |
| Q2 FY2018 | Jun 30, 2018 | $6.49B | +11.3% |
| Q1 FY2018 | Mar 31, 2018 | $5.77B | +4.6% |
| Q4 FY2017 | Dec 31, 2017 | $5.62B | +2.4% |
| Q3 FY2017 | Sep 30, 2017 | $5.68B | – |
| Q2 FY2017 | Jun 30, 2017 | $5.84B | – |
| Q1 FY2017 | Mar 31, 2017 | $5.51B | – |
| Q4 FY2016 | Dec 31, 2016 | $5.48B | – |
See a number that looks wrong?